This study investigated the dosimetric effects of different dose calculation algorithm for lung stereotactic ablative radiotherapy (SABR) using flattening filter-free (FFF) beams. A total of 10 patients with lung cancer who were treated with SABR were evaluated. All treatment plans were created using an Acuros XB (AXB) of an Eclipse treatment planning system. An additional plans for comparison of different alagorithm recalcuated with anisotropic analytic algorithm (AAA) algorithm. To address both algorithms, the cumulative dose-volume histogram (DVH) was analyzed for the planning target volume (PTV) and organs at risk (OARs). Technical parameters, such as the computation times and total monitor units (MUs), were also evaluated. A comparison analysis of DVHs from these plans revealed the PTV for AXB estimated a higher maximum dose (5.2%) and lower minimum dose (4.2%) than that of the AAA. The highest dose difference observed 7.06% for the PTV V105%. The maximum dose to the lung was also slightly larger in the AXB plans. The percentate volumes of the ipsilateral lung (V5, V10, V20) receiving 5, 10, and 20 Gy were also larger in AXB plans than for AAA plans. However, these parameters were comparable between both AAA and AXB plans for the contralateral lung. The differences of the maximum dose for the spinal cord and heart were also small. The computation time of AXB plans was 13.7% shorter than that of AAA plans. The average MUs were 3.47% larger for AXB plans than for AAA plans. The results of this study suggest that AXB algorithm can provide advantages such as accurate dose calculations and reduced computation time in lung SABR plan using FFF beams, especially for volumetric modulated arc therapy technique.
Introduction
The accuracy of dose calculations directly affects radiation treatment efficacy when an MV X-ray beam travels though media of different densities. Evidence exists that a 1% accuracy improvement results in a 2% increase in cure rates for patients with early-stage tumors.
1) The heterogeneous components of the body and the complexity of human anatomy require the sophisticated dose calculation algorithms of treatment planning systems (TPSs) to precisely calculate the dose prescribed to targets and organs at risk (OARs), for which the electron density may vary from low, such as that in the lungs, to high, such as that in dense bones. Various dose calculation algorithms have been developed to incorporate heterogeneity correction. Currently, most
clinical TPSs use convolution-based methods, such as collapsed cone convolution and anisotropic analytic algorithm (AAA), for pa-tient treatment planning. Inhomogeneity correction has greatly improved the accuracy of dose calculations, especially when low-density tissues such as lung tissue are involved in the treatment. 2) A good dose calculation algorithm should be able to calculate the dose accurately at the prescription point and tumor volume, as well as at the OARs. Therefore, dose calculation algorithms should be highly accurate throughout the entire treatment area. An inhomogeneity correction study on the AAA in the Eclipse TPS by Robinson 3) revealed that the discrepancy between his measurements and the AAA calculation exceeded 2% in low-density tissues, and the discrepancy was greater for 6-MV photon beams than for 15-MV photon beams. The widely used AAA is known to overestimate the dose at the air-tumor interface and underestimate the dose at the bone-tumor interface. The dosimetric accuracy of AXB has been investigated in several studies. A previous study by Han et al. 9) revealed that the differences of doses calculated using AXB and AAA plans in the lung region were as large as 15% in a single open filed.
In several other studies, validation results of AXB for inhomogeneous media indicated that the dose calculations from AXB were better than those from AAA when compared against the Monte Carlo (MC) results. 7, [10] [11] [12] However, the use of the two algorithms in stereotactic ablative radiotherapy (SABR) using a flattening filter-free (FFF) beam has not been investigated for lung cancer.
The purpose of this study was to evaluate the difference in the dose distribution of AXB and AAA plans implemented in a commercial TPS for lung SABR with an FFF beam. We compared the dosimetric parameters for the target and OARs according to the AAA and AXB plans.
Materials and Methods
Ten lung cancer patients who had treated with SBAR at our institution between May 2013 and January 2014 were enrolled in the current planning study, which was approved by our institutional review board (No. B-1406-254-109).
Dose calculation algorithms for heterogeneity correction
All calculations were performed using a new version of the The AAA is an analytical photon dose calculation algorithm based on a pencil beam convolution/superposition technique.
The tissue heterogeneity in the AAA is handled by radiologic scaling of primary photons and photon scatter kernel scaling in lateral directions according to the local electron density. 13, 14) AXB is considered similar to classic MC methods for accurate modelling of the dose deposition in heterogeneous media.
AXB utilizes the LBTE and solves numerically that describes the macroscopic behavior of radiation particles as they travel through and interact with the matter. A description of the original AXB algorithm for external beam was provide by
Vassiliev et al., 7) whereas a description of its implementation in Eclipse was reported by Fogliata et al.,. 15) The detailed mathematical formulas and implementations for AXB, including beam modelling, material assignments, and calculation options, were described in previously reported publications. The optimization goals were to ensure that the entire CTV received 95% of the prescribed dose and for the PTV to cover 95% of the volume that received 95% of the prescribed dose, with no PTV hot spot receiving 107% or more of the prescribed dose. Doses exceeding 107% were permitted only inside the target. The constraints for the OARs were a maximum dose (Dmax)＜30 Gy for the heart and Dmax＜20 Gy for the spinal cord. For the contralateral lung, the percentage volume receiving 20 Gy (V20) or more was restricted to 10%. For the ipsilateral lung, the dose constraint was V20＜30%
Plan evaluation and analyses
The dose-volume histogram (DVH) of the calculated SABR plans for lung cancer was generated in the Eclipse TPS. The average DVH of the PTV was generated for the AAA and AXB plans by averaging the data for the 10 analyzed patients.
For the PTV and CTV, the mean dose, minimum dose, maximum dose (high point dose), and homogeneity were compared. Homogeneity was evaluated using the sigma index (SI).
This index has a linear correlation with the equivalent normalized dose, and it represents the standard deviation of the differential DVH. Our previous study and other literature indicated that the SI was superior to the conventional homogeneity index because it provides complete information for the entire DVH curve in treatment plans. 17, 18) A value of conformity have been suggested, including the lesion coverage factor (LCF), healthy tissue conformity index (HTCI), and conformity number (CN). The LCF is the ratio of the PTV receiving 95% of the prescribed dose (V95%) to the PTV. The HTCI is the ratio between the PTV covered by the 95% of isodose and the volume of the 95% isodose. The CN is the product of the LCF and HTCI, integrating information regarding both the size of the 95% isodose and the degree of overlap with the PTV and was therefore used as the primary measure of conformity. [19] [20] [21] [22] For the lungs, the mean dose, maximum dose, and percentage volumes receiving 5 and 10 Gy (V5 and V10, respectively), as well as V20, were compared. The maximum dose was evaluated for the heart and spinal cord. Additionally, the technical parameters such as the computation times and total MUs for SABR plans using the AAA and AXB were compared. The difference in MUs between the AAA and AXB plans was Table 1 .
The mean values of the minimum, mean, and maximum doses for the PTV were 39.36, 47.98, and 53.63 Gy, respectively, when 48 Gy were delivered to the isocenter using the AXB. When the doses were recalculated using the AAA, these values were 41.52, 48.16, and 51.37 Gy, respectively.
Regarding the different calculation algorithms, the mean V95%, V100%, and V105% for the PTV displayed large differences, with the largest difference (7.06%) observed for the PTV V105%.
However, V95% and V100% differed by no more than 0.4% between the two plans for the CTV. The mean PTV and CTV SI was 3.89 and 1.28 Gy for the AXB, and 2.52 and 1.05 Gy for the AAA. The mean SI using the AXB was higher than that of the AAA. These results mean that 95% (2 standard deviations) and 99% (3 standard devations) of PTV using the AXB is encompassed 44.11∼51.89 to 42.83∼53.17 Gy, and that using the AAA is encompassed 45.48∼50.52 to 44.43∼ 51.57 Gy, respectively.
The mean V5, V10, and V20 for the ipsilateral lung were 24.60, 12.37, and 3.86%, respectively, when 48 Gy were delivered to the isocenter using the AXB. After recalculation with AAA, these values were 23.11, 11.41, and 3.63%, respectively.
The percentage volume to the ipsilateral lung was statistically reduced in the AAA calculation compared with the AXB calculation. However, the corresponding values for the contralateral lung were comparable (within 2%) between the AAA and AXB plans as shown in Table 2 . No significant difference was observed for the maximum dose to the spinal cord and heart between the plans.
The computation times for lung SABR between the AAA and AXB plans are listed in Table 3 . The AXB computation times by automatic optimization were faster than those of the AAA. The relative difference between these algorithms was 13.7%. Table 4 shows the percentage difference in MUs between the AAA and AXB plans for 10 patients, and the difference varied from −0.66 to 7.12%. The average percentage difference in MUs for the 10 patients was 3.47%.
Discussion
Two benefits can be expected from the use of FFF beams for radiation therapy; 1) The first benefit is a reduction in the out-of-field dose due to reduced head scatter and residual electron contamination. This leads to reduced exposure of normal tissue to scattered doses outside the field.
2) The second benefit is a fast delivery time with larger dose rates due to removal of the flattening filter. This implies the possibility of delivering treatment up to a factor of four at 10 MV. 23) The stereotactic VMAT technique with FFF beams has been confirmed as a powerful technique for irradiating many treatment sites, and the strategy is associated with higher dose conformity to the tumor and decreased intra-fraction movements because of the shorter treatment time. [24] [25] [26] [27] In our institution, lung SABR treatments possessing these advantages were administered using stereotactic VMAT with 6-MV FFF beams.
The dosimetric accuracy of AXB for intensity-modulated radiation therapy and VMAT plans with FFF beams has been investigated in several studies. 9, 12, 28) In the current study, we investigated the dosimetric differences between AXB and AAA plans for lung SABR with FFF beams.
A comparison of DVHs from these plans revealed that the AXB plans produced a high maximum dose and lower mini- The maximum dose delivered to the lungs was slightly larger in the AXB plans than in the AAA plans. The differences in lung doses calculated by the two algorithms were dependent on patient-related factors such as the field size of the target, location of the target inside the lungs, and density of the lungs. The previous study reported by Bush et al. indicated that the AAA can underestimate or overestimate the lung dose depending on the actual combination of field size, target location, and lung density.
10)
The values of V5, V10, and V20 for the ipsilateral lung were larger (＞6%) in the AXB plans than in the AAA plans. For the contralateral lung, these parameters were comparable between the plans. The low doses to the contralateral lung were mainly contributed from the exit doses because beam entrance though the contralateral lung was avoided.
The dose differences between the models for the other OARs were small. However, there was a significant difference in the calculation time between the AAA and AXB plans, including a difference of approximately 21% for patient 4. We found that the use of AXB could reduce the total computation time for VMAT plans using FFF beams, which have a large number of orientations. This is mostly due to the fact that the primary source component needs to be calculated for each beam via ray tracing, whereas the scatter components are calculated only once regardless of the number of beam angles.
The average number of MU differences for all patients was larger for the AXB plans than for the AAA plans, excluding patient 3. These outcomes indicated that application of AXB plans results in a 3.47% increase of the delivered dose relative to the AAA plans ( Table 5 ). The greatest difference (7.12%)
of MUs was observed in patient 4 with the smallest PTV. For larger PTVs, these differences of MUs from the 2 algorithms were decreased. The PTV margin of this patient was included with air in the PTV distant from soft tissue. The dose at the periphery of the PTV is likely to decrease because the PTV margin is covered with air, while in the PTV adjacent chest wall, the dose at the PTV is less likely to decrease because the PTV margin is close to or overlaps with soft tissues. The
MUs in the AXB plans had to be increased in order to obtain the suitable PTV coverage as in the AAA plans. We found that the percentage difference in MUs between the models is dependent on the individual patient anatomy, including the target size and its position. Our results are comparable to those of Narabayashi et al., who reported that the distance from the PTV margin to the chest wall was significantly correlated with the rate of increase in MUs.
29)

Conclusion
In SABR plans using FFF beams for lung cancer, we investigated the impact of two different dose calculation algorithms with heterogeneity correction on the dose distribution. On average, the AXB calculations produced smaller magnitudes of V95% and V100% for the CTV and PTV but a larger V105%. The AXB plans also predicted larger homogeneity index and smaller conformity index values than the AAA plans. For the ipsilateral lung, V5, V10, and V20 were larger in AXB plans than in AAA plans. However, these values were similar for the contralateral lung. The averaged maximum doses delivered to the spinal cord and heart also were similar between the AAA and AXB plans. The AXB algorithm provided advantages such as accurate dose calculations and reduced computation time in lung SABR plan using FFF beams, especially for VMAT planning.
